Isogenix is an Oxford University spin-out developing breakthrough therapies for the treatment of ALS and other neurodegenerative diseases, utilizing insights from protein isoforms and advanced technologies
Isogenix is an Oxford University spin-out developing breakthrough therapies for the treatment of ALS and other neurodegenerative diseases, utilizing insights from protein isoforms and advanced technologies.